Cantel Medical Corp. (CMN) Releases Earnings Results, Beats Expectations By $0.03 EPS

Cantel Medical Corp. (CMN) announced its most recent quarterly financial results on Thursday, Sep-29-2016. CMN said it had a profit of $0.48 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $0.45. The company posted revenue of $179.00 million in the period, compared to analysts expectations of $178.58 million. CMN’s revenue was up 18.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.

Many Wall Street Analysts have commented on Cantel Medical Corp.. Cantel Medical Corp. was Initiated by Needham to “Hold” on Aug 24, 2016.

Cantel Medical Corp. closed down -0.05 points or -0.06% at $80.23 with 1,80,180 shares getting traded on Tuesday. Post opening the session at $80.18, the shares hit an intraday low of $79.81 and an intraday high of $80.475 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

In a different news, on Jun 21, 2016, Jorgen B Hansen (President and COO) sold 2,000 shares at $72.44 per share price. According to the SEC, on Jun 14, 2016, Eric W Nodiff (EVP and General Counsel) sold 2,574 shares at $72.97 per share price. On Jun 14, 2016, Mark N. Diker (director) sold 7,000 shares at $73.30 per share price, according to the Form-4 filing with the securities and exchange commission.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training.

Cantel Medical Corp.

Leave a Reply

Cantel Medical Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cantel Medical Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.